Clinical Trial Access ICAN has partnered with research institutions and launched the Exon 20 Group to improve access to clinical trials for advanced cancer patients. This positions ICAN as a potential partner for pharma, biotech, and CROs seeking patient recruitment, trial matching, and advocacy programs to boost trial enrollment and patient engagement.

Digital Fundraising With a WordPress/MySQL stack, Google Analytics, and an active online presence, ICAN demonstrates digital fundraising and advocacy capabilities. There is a sales opportunity to offer integrated donor CRM, campaign analytics, multi-channel fundraising tools, and white-label advocacy platforms to scale donor acquisition and retention.

Global Reach ICAN serves Stage IV cancer patients worldwide, indicating a scalable network for patient education and advocacy. Opportunities exist to provide localization and translation services, international partnerships, and licensing of education resources to clinics, NGOs, and global partners.

Tool Licensing ICAN previously co-developed Remission Coach as a web-based cancer management tool, signaling openness to health-tech collaborations. A potential sales opportunity is licensing or co-developing Remission Coach or similar tools to healthcare providers, hospitals, or other nonprofits with ongoing support and customization options.

Strategic Partnerships ICAN’s mid-size nonprofit profile with substantial revenue and a history of research collaborations suggests strong potential for corporate sponsorships, CSR initiatives, and research funding partnerships. Target pharma, medtech, and philanthropic brands to sponsor advocacy programs, education initiatives, and patient-support projects.